Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH2 DNAH1	1.43e-04	18	115	3	GO:0008569
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 DHX40 DNAH2 ABCB6 TWNK HELQ DNAH1 SLC27A1 SMARCA2 SMARCA4 VCP SLC27A3	2.21e-04	614	115	12	GO:0140657
GeneOntologyMolecularFunction	heme binding	CYP1A1 CYP1A2 ABCB6 COX15 CYP2W1 PXDN	2.69e-04	154	115	6	GO:0020037
GeneOntologyMolecularFunction	tetrapyrrole binding	CYP1A1 CYP1A2 ABCB6 COX15 CYP2W1 PXDN	3.77e-04	164	115	6	GO:0046906
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH2 DNAH1	1.99e-05	10	117	3	GO:0036156
HumanPheno	Prominent interphalangeal joints	SMARCA2 SMARCA4 TAF4	1.10e-05	6	43	3	HP:0006237
Domain	Cyt_P450_E_grp-I_CYP1	CYP1A1 CYP1A2	3.69e-05	2	114	2	IPR008066
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	3.69e-05	2	114	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	3.69e-05	2	114	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	3.69e-05	2	114	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	3.69e-05	2	114	2	PS51666
Domain	SnAC	SMARCA2 SMARCA4	3.69e-05	2	114	2	SM01314
Domain	SnAC	SMARCA2 SMARCA4	3.69e-05	2	114	2	IPR029295
Domain	QLQ	SMARCA2 SMARCA4	3.69e-05	2	114	2	PF08880
Domain	Dynein_HC_stalk	DNHD1 DNAH2 DNAH1	7.68e-05	14	114	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH2 DNAH1	7.68e-05	14	114	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH2 DNAH1	7.68e-05	14	114	3	PF08393
Domain	MT	DNHD1 DNAH2 DNAH1	7.68e-05	14	114	3	PF12777
Domain	DHC_fam	DNHD1 DNAH2 DNAH1	9.55e-05	15	114	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH2 DNAH1	9.55e-05	15	114	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH2 DNAH1	9.55e-05	15	114	3	IPR004273
Domain	HSA	SMARCA2 SMARCA4	2.20e-04	4	114	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	2.20e-04	4	114	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	2.20e-04	4	114	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	2.20e-04	4	114	2	PF07529
Domain	Gal_Oxase/kelch_b-propeller	RAG2 KLHL10 IPP KLHL5	4.63e-04	59	114	4	IPR011043
Domain	BRK	SMARCA2 SMARCA4	5.45e-04	6	114	2	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4	5.45e-04	6	114	2	IPR006576
Domain	BRK	SMARCA2 SMARCA4	5.45e-04	6	114	2	PF07533
Domain	Gal_Oxidase_b-propeller	KLHL10 IPP KLHL5	1.15e-03	34	114	3	IPR015916
Domain	Cys-rich_flank_reg_C	LRRC24 LRG1 IGFALS PXDN	2.25e-03	90	114	4	IPR000483
Domain	LRRCT	LRRC24 LRG1 IGFALS PXDN	2.25e-03	90	114	4	SM00082
Domain	Cyt_P450_E_grp-I	CYP1A1 CYP1A2 CYP2W1	2.61e-03	45	114	3	IPR002401
Domain	Link_dom	BCAN NCAN	2.76e-03	13	114	2	IPR000538
Domain	Xlink	BCAN NCAN	2.76e-03	13	114	2	PF00193
Domain	LINK_2	BCAN NCAN	2.76e-03	13	114	2	PS50963
Domain	LINK	BCAN NCAN	2.76e-03	13	114	2	SM00445
Domain	LINK_1	BCAN NCAN	2.76e-03	13	114	2	PS01241
Domain	LRRNT	LRRC24 LHCGR IGFALS PXDN	3.06e-03	98	114	4	IPR000372
Domain	LRRNT	LRRC24 LHCGR IGFALS PXDN	3.06e-03	98	114	4	SM00013
Domain	IG_LIKE	LRRC24 BCAN IL1RL2 TMEM81 PXDN HMCN2 FCGRT NCAN BTNL9	3.16e-03	491	114	9	PS50835
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH1	3.20e-03	14	114	2	IPR024317
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH1	3.20e-03	14	114	2	IPR011704
Domain	AAA_8	DNAH2 DNAH1	3.20e-03	14	114	2	PF12780
Domain	AAA_5	DNAH2 DNAH1	3.20e-03	14	114	2	PF07728
Domain	Ig-like_dom	LRRC24 BCAN IL1RL2 TMEM81 PXDN HMCN2 FCGRT NCAN BTNL9	3.70e-03	503	114	9	IPR007110
Domain	Ig-like_fold	LRRC24 BCAN IL1RL2 TMEM81 PXDN HMCN2 POMGNT2 FCGRT NCAN BTNL9 EPB42	3.93e-03	706	114	11	IPR013783
Domain	LRR_8	LRRC24 LRRC43 LRG1 IGFALS PXDN	3.99e-03	171	114	5	PF13855
Domain	Cyt_P450_CS	CYP1A1 CYP1A2 CYP2W1	4.16e-03	53	114	3	IPR017972
Domain	Helicase_C	DHX40 HELQ SMARCA2 SMARCA4	4.19e-03	107	114	4	PF00271
Domain	HELICc	DHX40 HELQ SMARCA2 SMARCA4	4.19e-03	107	114	4	SM00490
Domain	IG	LRRC24 BCAN IL1RL2 TMEM81 PXDN HMCN2 NCAN BTNL9	4.30e-03	421	114	8	SM00409
Domain	Ig_sub	LRRC24 BCAN IL1RL2 TMEM81 PXDN HMCN2 NCAN BTNL9	4.30e-03	421	114	8	IPR003599
Domain	Helicase_C	DHX40 HELQ SMARCA2 SMARCA4	4.33e-03	108	114	4	IPR001650
Domain	HELICASE_CTER	DHX40 HELQ SMARCA2 SMARCA4	4.48e-03	109	114	4	PS51194
Domain	HELICASE_ATP_BIND_1	DHX40 HELQ SMARCA2 SMARCA4	4.48e-03	109	114	4	PS51192
Domain	DEXDc	DHX40 HELQ SMARCA2 SMARCA4	4.48e-03	109	114	4	SM00487
Domain	Kelch-typ_b-propeller	RAG2 IPP KLHL5	4.61e-03	55	114	3	IPR015915
Domain	Helicase_ATP-bd	DHX40 HELQ SMARCA2 SMARCA4	4.63e-03	110	114	4	IPR014001
Domain	AMP-bd_C	SLC27A1 SLC27A3	4.73e-03	17	114	2	IPR025110
Domain	AMP-binding_C	SLC27A1 SLC27A3	4.73e-03	17	114	2	PF13193
Domain	CYTOCHROME_P450	CYP1A1 CYP1A2 CYP2W1	5.10e-03	57	114	3	PS00086
Domain	-	CYP1A1 CYP1A2 CYP2W1	5.35e-03	58	114	3	1.10.630.10
Domain	Kelch	KLHL10 IPP KLHL5	5.35e-03	58	114	3	SM00612
Domain	p450	CYP1A1 CYP1A2 CYP2W1	5.35e-03	58	114	3	PF00067
Domain	BACK	KLHL10 IPP KLHL5	5.89e-03	60	114	3	SM00875
Domain	Cyt_P450	CYP1A1 CYP1A2 CYP2W1	5.89e-03	60	114	3	IPR001128
Domain	-	DNHD1 DHX40 DNAH2 CHST6 ABCB6 TWNK HELQ DNAH1 SMARCA2 SMARCA4 VCP	5.91e-03	746	114	11	3.40.50.300
Pubmed	Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.	CEBPA SMARCA2 SMARCA4	1.48e-07	4	117	3	16452305
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	CA11 DNHD1 GLT8D2 SNX24 GLB1L GPR78 BCAN PIGU PLA2G15 TMEM81 DMKN CCNL1 OR10W1 BTNL9 SLC27A3	1.17e-06	985	117	15	12975309
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	CNTNAP3B PLOD3 BCHE PLA2G15 PXDN POMGNT2 TMEM131	1.46e-06	164	117	7	32409323
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	1.12e-05	2	117	2	8670841
Pubmed	Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture.	CYP1A1 CYP1A2	1.12e-05	2	117	2	2425809
Pubmed	Variants near CCNL1/LEKR1 and in ADCY5 and fetal growth characteristics in different trimesters.	ADCY5 CCNL1	1.12e-05	2	117	2	21307140
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23163725
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23076393
Pubmed	Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.	CYP1A1 CYP1A2	1.12e-05	2	117	2	3000715
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	1.12e-05	2	117	2	15576411
Pubmed	Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.	CYP1A1 CYP1A2	1.12e-05	2	117	2	12147246
Pubmed	Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.	CYP1A1 CYP1A2	1.12e-05	2	117	2	17852022
Pubmed	Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.	CYP1A1 CYP1A2	1.12e-05	2	117	2	14980704
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	1.12e-05	2	117	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	1.12e-05	2	117	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	1.12e-05	2	117	2	33027072
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23872584
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23088494
Pubmed	Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.	CYP1A1 CYP1A2	1.12e-05	2	117	2	7781742
Pubmed	Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.	CYP1A1 CYP1A2	1.12e-05	2	117	2	11207026
Pubmed	Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.	CYP1A1 CYP1A2	1.12e-05	2	117	2	3785172
Pubmed	Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.	CYP1A1 CYP1A2	1.12e-05	2	117	2	3860967
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	1.12e-05	2	117	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	1.12e-05	2	117	2	34812766
Pubmed	Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.	CYP1A1 CYP1A2	1.12e-05	2	117	2	16609368
Pubmed	Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.	CYP1A1 CYP1A2	1.12e-05	2	117	2	15094312
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	1.12e-05	2	117	2	30478150
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	1.12e-05	2	117	2	26807827
Pubmed	CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.	CYP1A1 CYP1A2	1.12e-05	2	117	2	19285097
Pubmed	[Association of polymorph variants of CYP1A2 and CYP1A1 genes with reproductive and thyroid diseases in female workers of petrochemical industry].	CYP1A1 CYP1A2	1.12e-05	2	117	2	22855999
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	1.12e-05	2	117	2	25808524
Pubmed	Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.	CYP1A1 CYP1A2	1.12e-05	2	117	2	12438513
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	1.12e-05	2	117	2	19144648
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	1.12e-05	2	117	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	1.12e-05	2	117	2	37634210
Pubmed	Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.	CYP1A1 CYP1A2	1.12e-05	2	117	2	21262253
Pubmed	Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.	CYP1A1 CYP1A2	1.12e-05	2	117	2	26953171
Pubmed	Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.	CYP1A1 CYP1A2	1.12e-05	2	117	2	18493746
Pubmed	Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.12e-05	2	117	2	32726451
Pubmed	A shuffled CYP1A library shows both structural integrity and functional diversity.	CYP1A1 CYP1A2	1.12e-05	2	117	2	17823232
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	1.12e-05	2	117	2	8208605
Pubmed	Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.12e-05	2	117	2	3988744
Pubmed	CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.	CYP1A1 CYP1A2	1.12e-05	2	117	2	26643992
Pubmed	Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.	CYP1A1 CYP1A2	1.12e-05	2	117	2	22949628
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	1.12e-05	2	117	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	1.12e-05	2	117	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	1.12e-05	2	117	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	1.12e-05	2	117	2	29848589
Pubmed	Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity.	CYP1A1 CYP1A2	1.12e-05	2	117	2	9295056
Pubmed	Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.	CYP1A1 CYP1A2	1.12e-05	2	117	2	25680282
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	1.12e-05	2	117	2	31150793
Pubmed	The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.	CEBPA SMARCA2	1.12e-05	2	117	2	14660596
Pubmed	Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.	CYP1A1 CYP1A2	1.12e-05	2	117	2	25703676
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	1.12e-05	2	117	2	9603422
Pubmed	Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.12e-05	2	117	2	4054433
Pubmed	Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.	CYP1A1 CYP1A2	1.12e-05	2	117	2	31147315
Pubmed	Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice.	CYP1A1 CYP1A2	1.12e-05	2	117	2	8001243
Pubmed	Metabolism of 4-n-nonylphenol by non-modified and CYP1A1- and CYP1A2-transgenic cell cultures of tobacco.	CYP1A1 CYP1A2	1.12e-05	2	117	2	16402549
Pubmed	The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.	CYP1A1 CYP1A2	1.12e-05	2	117	2	24443269
Pubmed	Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.	CYP1A1 CYP1A2	1.12e-05	2	117	2	16426572
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	1.12e-05	2	117	2	27097303
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	1.12e-05	2	117	2	28038711
Pubmed	The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population.	CYP1A1 CYP1A2	1.12e-05	2	117	2	33046100
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	1.12e-05	2	117	2	23963727
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	1.12e-05	2	117	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	1.12e-05	2	117	2	31375262
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	1.12e-05	2	117	2	17075831
Pubmed	Absence of birth-weight lowering effect of ADCY5 and near CCNL, but association of impaired glucose-insulin homeostasis with ADCY5 in Asian Indians.	ADCY5 CCNL1	1.12e-05	2	117	2	21712988
Pubmed	CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.	CYP1A1 CYP1A2	1.12e-05	2	117	2	19276377
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	1.12e-05	2	117	2	32855269
Pubmed	Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).	CYP1A1 CYP1A2	1.12e-05	2	117	2	17052995
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	1.12e-05	2	117	2	22721696
Pubmed	Differences in regulation of gene expression between Cyp1a-1 and Cyp1a-2 in adult mouse hepatocytes in primary culture.	CYP1A1 CYP1A2	1.12e-05	2	117	2	1335375
Pubmed	Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.	CYP1A1 CYP1A2	1.12e-05	2	117	2	8095225
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	1.12e-05	2	117	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	1.12e-05	2	117	2	11719516
Pubmed	A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes.	CYP1A1 CYP1A2	1.12e-05	2	117	2	16505155
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	1.12e-05	2	117	2	28706277
Pubmed	Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.12e-05	2	117	2	8274012
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	1.12e-05	2	117	2	21092585
Pubmed	Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.	CYP1A1 CYP1A2	1.12e-05	2	117	2	1452456
Pubmed	Amino-terminal sequence and structure of monoclonal antibody immunopurified cytochromes P-450.	CYP1A1 CYP1A2	1.12e-05	2	117	2	3718958
Pubmed	Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele.	CYP1A1 CYP1A2	1.12e-05	2	117	2	14637164
Pubmed	The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation.	EIF2AK4 VCP	1.12e-05	2	117	2	30626938
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	1.12e-05	2	117	2	26551623
Pubmed	Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment.	CYP1A1 CYP1A2	1.12e-05	2	117	2	16516144
Pubmed	Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.	CYP1A1 CYP1A2	1.12e-05	2	117	2	28698457
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	1.12e-05	2	117	2	19458193
Pubmed	[Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].	CYP1A1 CYP1A2	1.12e-05	2	117	2	18389617
Pubmed	Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P1-450 and P3-450.	CYP1A1 CYP1A2	1.12e-05	2	117	2	6548461
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	1.12e-05	2	117	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	1.12e-05	2	117	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	1.12e-05	2	117	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	1.12e-05	2	117	2	26356327
Pubmed	Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.	CYP1A1 CYP1A2	1.12e-05	2	117	2	34242741
Pubmed	Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery.	CYP1A1 CYP1A2	1.12e-05	2	117	2	10623596
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	1.12e-05	2	117	2	12566296
Pubmed	Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate.	CYP1A1 CYP1A2	1.12e-05	2	117	2	21081470
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	1.12e-05	2	117	2	31406271
Interaction	C1orf54 interactions	GLT8D2 LRRC24 GLB1L CNTNAP3 BCHE PXDN POMGNT2 TMEM131	4.91e-06	167	114	8	int:C1orf54
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN NCAN	1.12e-04	4	79	2	574
GeneFamily	Cytochrome P450 family 1	CYP1A1 CYP1A2	1.12e-04	4	79	2	1000
GeneFamily	Kelch like\|BTB domain containing	KLHL10 IPP KLHL5	8.15e-04	42	79	3	617
GeneFamily	N(alpha)-acetyltransferase subunits\|GCN5 related N-acetyltransferases	NAA15 NAA35	1.21e-03	12	79	2	660
GeneFamily	Dyneins, axonemal	DNAH2 DNAH1	2.46e-03	17	79	2	536
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; HL60; HG-U133A	GGA2 TRPM2 MARCHF6 FLAD1 SMARCA4 ANTKMT SAC3D1 TMEM131	6.53e-06	194	115	8	1408_DN
Drug	mS60	CYP1A1 CYP1A2 ITPR1 FLAD1	1.53e-05	30	115	4	CID000013078
Drug	2-methoxy-4-aminoazobenzene	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C053767
Drug	3,4,3',4'-tetrachloroazoxybenzene	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C013280
Drug	cloflucarban	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C005055
Drug	musk xylene	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C031447
Drug	sesamex	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C100180
Drug	Canthaxanthin	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:D016644
Drug	Pigment Yellow 74	CYP1A1 CYP1A2	2.53e-05	2	115	2	CID000022829
Drug	pyridoxal isonicotinoyl hydrazone	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C021079
Drug	nitroaniline	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C008625
Drug	7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C013478
Drug	2,7-dinitrofluorene	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C085049
Drug	beta-apo-8'-carotenal	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C110652
Drug	propachlor	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C011088
Drug	allocryptopine	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C109505
Drug	2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole	CYP1A1 CYP2W1	2.53e-05	2	115	2	ctd:C507816
Drug	2,7-FAA	CYP1A1 CYP1A2	2.53e-05	2	115	2	CID000009352
Drug	protopine	CYP1A1 CYP1A2	2.53e-05	2	115	2	ctd:C009093
Drug	ethyl-p-hydroxybenzoate	CYP1A1 CYP1A2 CEBPA	4.39e-05	14	115	3	ctd:C012313
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	GGA2 NAA15 MARCHF6 GTF2I SBF1 SMARCA2 SMARCA4	5.71e-05	193	115	7	3906_DN
Drug	Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A	GPR27 TRPM2 PRDM4 NPHP4 PLA2G15 FCGRT SMARCA4	5.90e-05	194	115	7	1783_UP
Drug	cryptotanshinone	CYP1A1 CYP1A2 BCHE	6.70e-05	16	115	3	ctd:C037886
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; HL60; HG-U133A	GGA2 GPR27 NPHP4 NAA35 YIPF1 SMARCA2 SLC27A3	6.71e-05	198	115	7	1390_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HG-U133A	GGA2 GPR27 AMBRA1 NAA35 RNF123 SMARCA4 ANTKMT	6.93e-05	199	115	7	1907_DN
Drug	Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; PC3; HT_HG-U133A	GGA2 TRPM2 SETDB1 SMARCA2 DEPDC5 SLC27A3 TRDMT1	6.93e-05	199	115	7	7141_UP
Drug	2,3-diaminotoluene	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C522525
Drug	2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C519626
Drug	scutellarein	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C458179
Drug	genkwanin	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C014568
Drug	1-methoxyrutaecarpine	CYP1A1 CYP1A2	7.56e-05	3	115	2	CID005319487
Drug	Suppressor Factors, Immunologic	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:D013491
Drug	alyssin	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C524315
Drug	Trichloroepoxypropane	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:D014239
Drug	3-aminofluorene	CYP1A1 CYP1A2	7.56e-05	3	115	2	CID000022818
Drug	1-aminofluorene	CYP1A1 CYP1A2	7.56e-05	3	115	2	CID000022817
Drug	2,2',4,6'-tetramethoxystilbene	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C541980
Drug	6-nitrobenzo(a)pyrene	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C034699
Drug	chlortoluron	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C007033
Drug	Aminoquinolines	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:D000634
Drug	7-(deoxyadenosin-N(6)--yl)aristolactam II	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C405699
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C057584
Drug	7-nitrobenzanthracene	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C038954
Drug	1,2-dichloroethylene	CYP1A1 CYP1A2	7.56e-05	3	115	2	ctd:C035384
Drug	2-aminoanthracene	CYP1A1 CYP1A2 IGFALS VCP	7.84e-05	45	115	4	CID000011937
Drug	musk xylene	CYP1A1 CYP1A2 IGFALS	8.11e-05	17	115	3	CID000062329
Drug	Benzofurans	CYP1A1 CYP1A2 CEBPA	9.69e-05	18	115	3	ctd:D001572
Drug	1-chloropyrene	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C040345
Drug	purpurin	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C511975
Drug	2-nitrofluoranthene	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C049030
Drug	7-methoxyresorufin	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C076580
Drug	2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C520611
Drug	musk ketone	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C031448
Drug	3,6-dinitrobenzopyrene	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C068923
Drug	PY74	CYP1A1 CYP1A2	1.51e-04	4	115	2	CID000017893
Drug	N-methyl-7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C041150
Drug	terbutryne	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C010347
Drug	thiacloprid	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C417209
Drug	5,5'-bis-trifluoromethyl-2,2'-dichlorobiphenyl	CYP1A1 CYP1A2	1.51e-04	4	115	2	CID000057528
Drug	1,2,3,5,6,7-hexachloronaphthalene	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C575652
Drug	CHEBI:697555	BCHE ITPR1	1.51e-04	4	115	2	CID009578246
Drug	KC 500	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C477388
Drug	3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C549241
Drug	3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C520945
Drug	tasquinimod	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C516109
Drug	3-hydroxyrutaecarpine	CYP1A1 CYP1A2	1.51e-04	4	115	2	CID000637395
Drug	sinensetin	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C059295
Drug	alpha-hederin	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C010177
Drug	4-aminofluorene	CYP1A1 CYP1A2	1.51e-04	4	115	2	CID000023488
Drug	Quinolinium Compounds	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:D011806
Drug	olivacine	CYP1A1 CYP1A2	1.51e-04	4	115	2	ctd:C011521
Drug	AC1Q6BAJ	CYP1A1 CYP1A2 BCHE	1.56e-04	21	115	3	CID000125675
Drug	Permethrin	CYP1A1 CYP1A2 CEBPA ABCB6 BCHE RASSF5 SLC27A1	2.21e-04	240	115	7	ctd:D026023
Drug	fluorene	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C041509
Drug	2,4,6-triphenyl-1-hexene	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C533342
Drug	1,2,3,4,6,7-hexachlorinated naphthalene	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C412791
Drug	furafylline	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C050131
Drug	4-methoxyglucobrassicin	CYP1A1 CYP1A2	2.50e-04	5	115	2	CID000656562
Drug	benzyl selenocyanate	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C054108
Drug	Uroporphyrinogens	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:D014577
Drug	aflatoxin B1-DNA adduct	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C072611
Drug	diphenyl	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C010574
Drug	5,12-naphthacenequinone	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C468646
Drug	6-nitrochrysene	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C035986
Drug	N-(hydroxymethyl)carbaryl	CYP1A1 CYP1A2	2.50e-04	5	115	2	CID000021341
Drug	Benz(a)Anthracenes	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:D001551
Drug	naphtho(2,3-a)pyrene	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C501268
Drug	benzyloxyresorufin	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C057754
Drug	N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C062567
Drug	glucoerucin	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C119493
Drug	bilobalide	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C073710
Drug	AC1L1SC7	CYP1A1 CYP1A2	2.50e-04	5	115	2	CID000009110
Drug	1,2,4-trihydroxy-9,10-anthracenedione	CYP1A1 CYP1A2	2.50e-04	5	115	2	ctd:C410870
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; HL60; HG-U133A	GGA2 TRPM2 AMBRA1 PRDM4 SLC7A9 SMARCA2	2.92e-04	178	115	6	1716_UP
Drug	tanshinone	CYP1A1 CYP1A2 CEBPA PSMD2 FLAD1	3.09e-04	116	115	5	ctd:C021751
Drug	Carbaryl	CYP1A1 CYP1A2 CEBPA BCHE	3.11e-04	64	115	4	ctd:D012721
Drug	5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate	CYP1A1 CYP1A2 CEBPA	3.36e-04	27	115	3	ctd:C521334
Drug	4'-methoxyflavone	CYP1A1 CYP1A2	3.74e-04	6	115	2	ctd:C487850
Disease	5-hydroxy-2-methylpyridine sulfate measurement	CYP1A1 CYP1A2	1.43e-05	2	112	2	EFO_0801051
Disease	serum clozapine measurement	CYP1A1 CYP1A2	1.43e-05	2	112	2	EFO_0600041
Disease	X-21286 measurement	CYP1A1 CYP1A2	8.53e-05	4	112	2	EFO_0800804
Disease	tumor necrosis factor ligand superfamily member 15 measurement	BCHE IGKV2-24	1.42e-04	5	112	2	EFO_0020794
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	1.42e-04	5	112	2	C3281201
Disease	C-reactive protein measurement	PRR30 LRRC43 PIGU ADCY5 CYP2W1 ITPR1 LHCGR HEYL GTF2I PXDN CCNL1 SMARCA4 TAF4 SLC27A3	1.93e-04	1206	112	14	EFO_0004458
Disease	porphyria cutanea tarda (is_implicated_in)	CYP1A1 CYP1A2	2.12e-04	6	112	2	DOID:3132 (is_implicated_in)
Disease	plasma clozapine measurement	CYP1A1 CYP1A2	3.94e-04	8	112	2	EFO_0600038
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	3.94e-04	8	112	2	DOID:0060308 (implicated_via_orthology)
Disease	advanced glycation end-product measurement	CYP1A1 CYP1A2	5.05e-04	9	112	2	EFO_0007819
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	5.05e-04	9	112	2	DOID:0050340 (implicated_via_orthology)
Disease	theophylline measurement	CYP1A1 CYP1A2	6.30e-04	10	112	2	EFO_0021180
Disease	sweet beverage consumption measurement	CYP1A1 CYP1A2	6.30e-04	10	112	2	EFO_0010090
Disease	1,7-dimethylurate measurement	CYP1A1 CYP1A2	6.30e-04	10	112	2	EFO_0021512
Disease	Neuroblastoma	BCHE RASSF5 ALK	7.64e-04	47	112	3	C0027819
Disease	1-methylxanthine measurement	CYP1A1 CYP1A2	7.68e-04	11	112	2	EFO_0021174
Disease	plasma N-desmethylclozapine measurement	CYP1A1 CYP1A2	7.68e-04	11	112	2	EFO_0600039
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A1 CYP1A2	7.68e-04	11	112	2	EFO_0800951
Disease	eosinophil measurement	PSMD2 PXDN SMARCA4 TMEM131	7.78e-04	108	112	4	EFO_0803540
Disease	paraxanthine measurement	CYP1A1 CYP1A2	9.19e-04	12	112	2	EFO_0021178
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	1.08e-03	13	112	2	C0265338
Disease	Birth Weight	CYP1A1 ADCY5	1.26e-03	14	112	2	C0005612
Disease	1,3,7-trimethylurate measurement	CYP1A1 CYP1A2	1.45e-03	15	112	2	EFO_0021172
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 CYP1A2	1.65e-03	16	112	2	EFO_0004330, EFO_0006782
Disease	arterial stiffness measurement	SMARCA2 TAF4 SEC14L5	1.87e-03	64	112	3	EFO_0004517
Disease	sodium-coupled monocarboxylate transporter 1 measurement	BCHE SMARCA4	2.34e-03	19	112	2	EFO_0802076
Disease	caffeine metabolite measurement	CYP1A1 CYP1A2	2.34e-03	19	112	2	EFO_0007872
Disease	Lung Injury	CYP1A1 CYP1A2	2.86e-03	21	112	2	C0273115
Disease	Chronic Lung Injury	CYP1A1 CYP1A2	2.86e-03	21	112	2	C2350344
Disease	Ovarian Serous Adenocarcinoma	MAST1 ALK	3.43e-03	23	112	2	C1335177
Disease	cancer (implicated_via_orthology)	FLAD1 SMARCA2 SMARCA4 DEPDC5 ALK	3.63e-03	268	112	5	DOID:162 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IILYFRAPVRAFLPA	EPB42	41	P16452
TLRVPPRRLGVFLDY	BTNL9	441	Q6UXG8
FLGIPYAQPPLGRLR	BCHE	56	P06276
LQPPFEARFLRFLPL	CNTNAP3	146	Q9BZ76
LLLPQPDLRYLFLNG	LRG1	231	P02750
EPARLLPLAANGRLY	C8orf82	141	Q6P1X6
PRAYAVAIPLAAGLL	DPM2	46	O94777
RYDLLIPQFRGPQAL	EIF2AK4	1351	Q9P2K8
PPRLLRYLQLDFEGV	ASB10	451	Q8WXI3
LFAGLLQRYRLLPPP	CYP2W1	446	Q8TAV3
AGPRISPYVLQLLLA	ABCB6	66	Q9NP58
ALPNSLLAPLGRLRY	IGFALS	496	P35858
RYGFLLPARQILPTA	CPA2	386	P48052
KRVLYDPFLPPLRLS	CA11	76	O75493
AAIIYLGPFPPLRRQ	DNHD1	3446	Q96M86
AARPPLQLPYLAVLA	ADCY5	261	O95622
LGRFVPRRFLLPEYL	AMBRA1	801	Q9C0C7
YLAARALQIPLPTRP	CCNL1	251	Q9UK58
FRRVPLRLQVPYVGA	ANTKMT	46	Q9BQD7
ANLYRIRVDLPLGSP	RAG2	231	P55895
PGELYRVLPLRSLIQ	PDZRN4	61	Q6ZMN7
RPYRVGLLPDGLLFL	PLA2G15	6	Q8NCC3
SIADRPLYLRLLAGP	RASSF5	336	Q8WWW0
FIPILRYLPNPSLNA	CYP1A1	236	P04798
LDFFPILRYLPNPAL	CYP1A2	236	P05177
IRFPLLPPQRLLKYI	IPP	226	Q9Y573
LPLAQVFGRPRLRYE	BCAN	821	Q96GW7
QPTPFLPRFLQRLLL	PLOD3	306	O60568
LPRFLQRLLLLDYPP	PLOD3	311	O60568
YGDPLRAQLFIPLNI	DEPDC5	1431	O75140
LGTPLLNPLIYALRN	OR10W1	271	Q8NGF6
HPFLYGLLQRPVRLA	GPR62	286	Q9BZJ7
LRYIEPGAFINLPRL	LHCGR	111	P22888
FRQREGPFYPTLRLL	MCTS1	71	Q9ULC4
DYPPLVSGALQLLFR	ITPR1	1081	Q14643
LRLYPGIPAALVRAF	ASPG	241	Q86U10
STLQYRLLPLPLGVR	HMCN2	4961	Q8NDA2
ILGFPLRPNRGLYQL	BMP15	116	O95972
LRVLVRPGAVPQAYL	GPR27	306	Q9NS67
FYPPELQLRFLRNGL	FCGRT	226	P55899
LLSLFPGALPVQIRY	PCDHGB2	21	Q9Y5G2
EPGALAPLAALRRLY	LRRC24	66	Q50LG9
QPYRRPLNFPLRIFL	MARCHF6	621	O60337
AYPIPALRTAPLRRA	HEYL	211	Q9NQ87
LPPLIVYDRNGFRIL	GGA2	486	Q9UJY4
LLQPLNFVRFYLPLL	GLT8D2	131	Q9H1C3
ERLYRFPPGTLLAPR	LMNTD2	401	Q8IXW0
PPALLPYLEQFRRIV	TWNK	291	Q96RR1
DLLPLFYTLRQFPGL	POMGNT2	171	Q8NAT1
AFILTGIPYPLRLRT	OR10G3	11	Q8NGC4
LLVLPFPFTLRNLRY	OR51A4	156	Q8NGJ6
PFTYSLLRRPFRQVL	GPR78	291	Q96P69
LAYIRLPLLAPQFLA	KLHL5	406	Q96PQ7
PLTLFVPGLLYLLQR	PIGU	196	Q9H490
KYPRGLVPRRLPLNF	NAA15	286	Q9BXJ9
PRYIIRQLGLTRDPF	MAST1	321	Q9Y2H9
FHLRGSLAPQLYLRP	NPHP4	1041	O75161
VVPLLNPFIYSLRNR	OR5K1	281	Q8NHB7
DPGFLRPQRAALYIL	SBF1	1316	O95248
ADLLLALALPPRIAY	F2RL3	121	Q96RI0
RIPALLYLPGQQSLL	NEU2	21	Q9Y3R4
LLRPPASLQYRFARI	POP1	1006	Q99575
YLARLLGLQRHVPPL	FJX1	196	Q86VR8
ILQLPAPDFRAYLIG	IL1RL2	326	Q9HB29
LINSPYRPRKNPLFI	DNAH1	646	Q9P2D7
LYFKRLIQIPRLPEG	HIP1R	271	O75146
RCYGRALRLLLTLPP	FKBPL	231	Q9UIM3
NPLTRPRLPYAILFA	KLHL10	281	Q6JEL2
VPPPSTRALLYFSRL	DMKN	381	Q6E0U4
LYERVGAPALRPLVI	CEBPA	146	P49715
QPSRIPRPLAYVFLG	GAS2L2	791	Q8NHY3
SVLYRLCLQPLPLRA	FNDC10	141	F2Z333
VRRLTPAPAIIFYGI	SLC7A9	346	P82251
LYVPRFLLFPRGALN	GLB1L	586	Q6UWU2
LLTLRSLPRGNYLVP	CDH26	561	Q8IXH8
GQPPRLLIYKISNRF	IGKV2-24	66	A0A0C4DH68
FPPLRALKGRQYLPL	COX15	6	Q7KZN9
QYLPLLAPRAAPRAQ	COX15	16	Q7KZN9
GVNLPARRVILRAPY	HELQ	676	Q8TDG4
PSTYGIPRLERILLA	GTF2I	411	P78347
VYLFPGIPELLRRVL	FLAD1	251	Q8NFF5
VIRFPYLDPPNERLI	DHX40	446	Q8IX18
GTVRGPYIPALLRLL	DNAH2	161	Q9P225
PYIPALLRLLGGVFA	DNAH2	166	Q9P225
NYPETLGRLLIVRAP	SEC14L5	411	O43304
RLFRLLQTLPYLPSC	SAC3D1	276	A6NKF1
LQPPFEARFLRFLPL	CNTNAP3B	146	Q96NU0
RLLVLQGNPLALVPY	LRRC43	251	Q8N309
RTILPGILSYLADRP	PRDM4	106	Q9UKN5
IDPYKLLPLQRFLPR	GAR1	146	Q9NY12
PPYFSRTLQCLGLRL	RPUSD3	336	Q6P087
PYLVPFLKRSLPALR	TAF4	651	O00268
PTSLGIPNSRLRYFL	TRDMT1	151	O14717
YVAPRRILLTGTPLQ	SMARCA2	871	P51531
LRLPLRYPRALTALG	SPATA5L1	216	Q9BVQ7
YGEPTLRRAVPLALA	PSMD2	681	Q13200
YPRRRANATLLLGPL	NCAN	116	O14594
YVAPRRLLLTGTPLQ	SMARCA4	901	P51532
LPIPILSAQLRYCGR	OR56A3	161	Q8NH54
KLLPYLTLLPGRDFR	VHLL	76	Q6RSH7
PRRPYASPLLNGLAL	SOX8	411	P57073
GKNPLLVPLLYDFRR	SETDB1	596	Q15047
PSLFRVYARDLLLPP	ALK	61	Q9UM73
ATLKPPPFLRGRYRL	CHST6	256	Q9GZX3
VPRALQPQLGILRYF	PLK3	521	Q9H4B4
RLRYLPTGSFPFLLL	TUSC3	16	Q13454
LLPIPGKNFVRLYIR	YIPF1	101	Q9Y548
QRLLPPTFPRYAKII	NAA35	306	Q5VZE5
QPVLLFLRDPYVLPA	SNX24	131	Q9Y343
PAILRPGRLDQLIYI	VCP	631	P55072
LAPYARPIFLRLLPQ	SLC27A1	576	Q6PCB7
ENLPPYARPRFLRLQ	SLC27A3	611	Q5K4L6
LRLYRFSPIVPDLGL	RNF123	386	Q5XPI4
RLIPATLYPGRVILS	TRPM2	886	O94759
ARSLLYQFRLLPRIP	TBC1D16	686	Q8TBP0
VPNPYRLRPFLGARV	TMEM131	206	Q92545
PRSPNDLLALFRYPR	PXDN	651	Q92626
PGLNILIPVLDRIRY	STOML2	61	Q9UJZ1
VKRLYFGLRVLPPNL	TMEM81	171	Q6P7N7
LPPFPVLSTYRLQSR	TOGARAM1	11	Q9Y4F4
PRYRTGPRLLAFPQL	PRR30	266	Q53SZ7